Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolomics in multiple sclerosis

11 Jan 2016

Abstract excerpt

Multiple sclerosis (MS) is a chronic demyelinating disorder of the central nervous system with inflammatory and degenerative components. The cause of MS remains unknown although genetic and environmental factors appear to play a role in its etiopathogenesis. Metabolomics is a new "omics" technology that aims at measuring small molecules in various biological matrices and can provide information that is not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Multiple Sclerosis Research Studies
Share to Mycobacterium research and diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26754801
DOI: 10.1177/1352458515622827

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolomics in multiple sclerosisPMID 26754801Read ↗

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisSemantic proximity Read ↗

Metabolic Changes in Autoimmune DiseasesSemantic proximity Read ↗

Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?Semantic proximity Read ↗

Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosisSemantic proximity Read ↗

Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicineSemantic proximity Read ↗

Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics, and microbiomicsSemantic proximity Read ↗

Metabolome-based signature of disease pathology in MSSemantic proximity Read ↗

Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity Read ↗

Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System DemyelinationSemantic proximity Read ↗

Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed the testable therapeutic targetSemantic proximity Read ↗

Mass Spectrometry-based Metabolomics in Translational Research.Semantic proximity Read ↗

Utility of an untargeted metabolomics approach using a 2D GC-GC‒MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.